• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) UNK VOLBELLA; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) UNK VOLBELLA; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number UNK VOLBELLA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Edema (1820)
Event Date 05/28/2020
Event Type  Injury  
Manufacturer Narrative
Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.The filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional reports patient injection with juvéderm volbella® xc, juvéderm vollure¿ xc, and juvéderm voluma® xc (5 syringes total) into the midface, prejowl sulcus, marionette, upper cutaneous lip.There were no events during procedure and injector took very good care with aseptic technique.The patient presented 6 days after injection with severe facial swelling and visited the er.The entire face swelled (moon faced) and was very tense.In clinic, patient was not found to have any tenderness, pain, warmness to touch, was afebrile and had no other symptoms besides tense edema.It was later found to be the midface primarily, not the mouth.Patient was placed on doxycycline, high dose antihistamines and cephalexin 2 days post injection.After a few days without relief, prednisone at a dose of 60mg which was been tapering off since was prescribed.The patient is currently on prednisone 5mg every other day.The patient was also experienced fluctuant areas in the midface where juvéderm voluma® xc was injected.Physician drained the affected areas and had them cultured, but nothing grew out (this was performed after antibiotics had been started).The patient completed about 9 days of antibiotics.The physician also injected hyaluronidase in those areas and received in total around 150 units.2 months post injection, patient developed a more "traditional" immune nodule on the lower face where juvéderm vollure¿ xc was applied to the marionette area.Patient treated with weekly hylenex injections to the affected areas.Nodule resolved almost immediately after dissolution and did not recur.Patient remains off prednisone and antibiotics, just on antihistamines.3 months post injection, another fluctuant nodule appeared on the left cheek and was present for 48 hours.Injector completed the "most work" on the patient in this area.1 cc of yellow/white material that appeared to be purulent was aspirated.Treating healthcare professional obtained an excellent sample for another culture when patient had been off of antibiotics for several weeks.An additional culture was completed.Patient is embarrassed about the current state of the face.This is the same event and the same patient reported under mdr id# 3005113652-2020-00454 (allergan complaint #(b)(4)) and mdr id# 3005113652-2020-00452 (allergan complaint #(b)(4)) this mdr is being submitted for the juvéderm volbella® xc injection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK VOLBELLA
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
michelle burgess
12331-a riata trace parkway
building 3
austin, TX 78727
7372473605
MDR Report Key10417139
MDR Text Key203645861
Report Number3005113652-2020-00453
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK VOLBELLA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/21/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-